Models for Predicting Effective HIV Chemoprevention in Women
Melanie R. Nicol(University of Minnesota), Angela D. M. Kashuba(University of North Carolina at Chapel Hill), Elizabeth J. Geller(Dartmouth College), Yuri Fedoriw(University of North Carolina at Chapel Hill), Cindi W. Emerson(University of North Carolina at Chapel Hill), Craig Sykes(University of North Carolina at Chapel Hill), Heather M. A. Prince(Indiana University School of Medicine), Julie A. Nelson(University of North Carolina at Chapel Hill), Kristine B. Patterson(University of North Carolina at Chapel Hill), Myron S. Cohen(University of North Carolina at Chapel Hill)
Cited by 21
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
|New England Journal of Medicine|2020|1.4k
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
|Nature|2012|1.2k
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
|New England Journal of Medicine|2021|557